apollo
logo
0Login

BENFOTIAMINE+METFORMIN

About BENFOTIAMINE+METFORMIN

BENFOTIAMINE+METFORMIN belongs to the class of antidiabetic drugs, primarily used to treat type 2 diabetes mellitus. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produce little or no insulin at all. 

BENFOTIAMINE+METFORMIN is composed of Benfotiamine and Metformin. Benfotiamine is a synthetic form of Vitamin B1 or Thiamine. It treats diabetic neuropathy (nerve damage due to diabetes) and relieves symptoms like numbness, tingling, burning and needle-like sensations in the hands and feet. Metformin belongs to the class of biguanides and manages blood sugar levels, particularly in obese patients. It exhibits a nonpancreatic effect to reduce blood glucose levels without increasing insulin secretion.

Take BENFOTIAMINE+METFORMIN as advised by your doctor. Some common side effects of BENFOTIAMINE+METFORMIN include nausea, diarrhoea, stomach pain, loss of appetite and taste changes. Sometimes, BENFOTIAMINE+METFORMIN can cause side effects like lactic acidosis (a rare but serious metabolic complication of excess lactic acid in the blood that is caused by metformin accumulation) and diabetic ketoacidosis (excess production of blood acids (ketones)). These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor. 

BENFOTIAMINE+METFORMIN may cause hypoglycaemia (low blood sugar); hence it is advised to take healthy food with enough calories and avoid heavy exercises. Do not take or stop this medicine if the doctor did not advise you to do so. Before starting BENFOTIAMINE+METFORMIN, let your doctor know if you have any medical history of heart, kidney or liver diseases, breathing problems, blood disorders, and alcohol use. It is advised to avoid your alcohol intake while using BENFOTIAMINE+METFORMIN to decrease the risk of lactic acidosis and lowering of blood sugar levels. Please seek medical advice before using BENFOTIAMINE+METFORMIN if you are a pregnant or breastfeeding woman.

Uses of BENFOTIAMINE+METFORMIN

Type 2 Diabetes mellitus.

Medicinal Benefits

BENFOTIAMINE+METFORMIN treats type 2 diabetes mellitus and contains Metformin and Benfotiamine. Benfotiamine is a lab-made version of vitamin B1, also called thiamine. The body turns Benfotiamine into thiamine. Thiamine helps in delivering essential nutrients to the nerves. It treats diabetic neuropathy (nerve damage due to diabetes) and relieves symptoms like numbness, tingling, burning, and needle-like sensations in the hands and feet. Metformin is a biguanide and manages blood sugar levels, particularly in obese patients. It exhibits a nonpancreatic effect to reduce blood glucose levels without increasing insulin secretion. It is also known as an insulin sensitizer as it increases the effects of insulin. Metformin is considered a unique antidiabetic drug since it does not cause hypoglycemia (lowered blood sugar levels). 

Directions for Use

Swallow it as a whole with water; do not crush, break or chew it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of BENFOTIAMINE+METFORMIN

  • Nausea
  • Diarrhoea
  • Stomach pain
  • Loss of appetite 
  • Taste changes
  • Lactic acidosis (rare)
  • Diabetic ketoacidosis (rare)

Patients Concern

Disease/Condition Glossary

Diabetes mellitus, also known as adult-onset diabetes, is a metabolic disease that causes high blood sugar levels. It is type 2 diabetes and occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produce little or no insulin at all. This disease mostly occurs in people aged above 40 years but can also occur in childhood based on the risk factors. The treatment includes oral glucose-lowering medicines and insulin shots. 

FAQs

BENFOTIAMINE+METFORMIN contains Metformin and Benfotiamine. Metformin lowers the blood sugar levels in type 2 diabetes mellitus by decreasing the production and absorption of sugar in the body. Benfotiamine, a synthetic form of Vitamin B1, reduces diabetic neuropathy symptoms, such as numbness, tingling, and needle-like sensation in the hands and feet.

BENFOTIAMINE+METFORMIN may cause low blood sugar levels (hypoglycaemia) and can make you hungry, dizzy, irritable, confused, anxious, or shaky. Hence, it is advised to take BENFOTIAMINE+METFORMIN with a meal. To immediately treat hypoglycaemia, it is advised to eat or drink fast-acting sugar sources like fruit juices, hard candy, raisins, or non-diet soda.

Your doctor may advise BENFOTIAMINE+METFORMIN with or without other medications to control your blood sugar levels. However, it is advised to maintain a proper diet and exercise to achieve the controlled blood sugar levels while using BENFOTIAMINE+METFORMIN with or without other antidiabetic drugs.

While using BENFOTIAMINE+METFORMIN, if you experience vomiting, stomach/abdominal pain, muscle cramps, sick feeling, severe tiredness, difficulty in breathing, or reduced body temperature and heartbeat, it is important to seek immediate medical help since these are the symptoms of lactic acidosis. Lactic acidosis is a rare but serious complication caused due to accumulation of metformin. It is a medical emergency and needs immediate treatment. Please consult your doctor for further information.

It is not recommended to use BENFOTIAMINE+METFORMIN along with water pills/diuretics. Simultaneous use of BENFOTIAMINE+METFORMIN and water pills causes dehydration and may increase the risk of lactic acidosis.

Take the missed dose as soon as possible. However, if it is time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose.

Available Medicines for

BENFOTIAMINE+METFORMIN

0
VIEW MORE PRODUCTS